MORE►
cancer research
Ayaz Najafov, Ph.D., led a UT Southwestern study that identified the protein responsible for rupturing cell membranes during necroptotic cell death. [Composite: DI Studio, source images, UTSW]
UT Southwestern Research Findings on Inflammatory Cell Death Could Lead to New Treatments for Sepsis, Crohn’s, Alzheimer’s, ALS, and Cancer
by Quincy Preston | Dec 22, 2025
The discovery of a protein tied to necroptosis—a type of cell death—could help fight severe infections and inflammation.
by Sandra Engelland |
Dec 11, 2025
InterAct, which launched inside BioLabs at Pegasus Park, is a preclinical stage biotech company developing AAV8-based gene therapies for metastatic cancer, with an initial focus on breast cancer-derived liver metastases.
MORE►
by Dallas Innovates | Staff Report |
Dec 5, 2025
The Cancer Prevention & Research Institute of Texas offers funding opportunities for promising cancer research, product development, and prevention programs. The state-funded initiative stands as the second-largest public backer of cancer research in the U.S. after the National Cancer Institute.
MORE►
by Lance Murray |
Jul 2, 2025
UTA and UT Southwestern researchers have built BIT, a new computational framework that helps scientists identify the proteins that switch genes on and off in cancer and other diseases. The work could pave the way to more targeted treatments and boost gene research accuracy.
MORE►
In this image, the proteasome—a cell’s protein disposal system—is shown in tan and grey. A protein called midnolin (in red) connects with two key parts of the proteasome, RPN1 (blue) and RPN11 (green), to help deliver damaged or unwanted proteins for breakdown. This interaction helps keep cells healthy by clearing out the cellular junk. [Image: UTSW]
UT Southwestern Maps a Cancer-Enabling Protein That Lets B-Cell Tumors Hang On—With a Nobel Laureate on the Case
by Lance Murray | Jun 16, 2025
The protein—implicated in blood cancers like leukemia, lymphoma, and multiple myeloma—was decoded in near-atomic detail by UT Southwestern researchers, including Nobel Prize winner Bruce Beutler. In lab models, turning off midnolin wiped out up to 92% of cancer cells—with minimal impact on healthy ones, according to UT Southwestern.
MORE►
by Lance Murray |
Oct 16, 2024
That brings to more than $96 million the amount the foundation has given since 1996 to support its two-fold mission: eliminating women-related cancers and ending domestic violence.
MORE►
by Lance Murray |
Sep 17, 2024
Texas Rangers first baseman Nathaniel Lowe leads a star-studded sports team of players and legends from the Dallas Cowboys, Dallas Stars, Dallas Mavericks, FC Dallas, and Dallas Wings in encouraging even more donations on North Texas Giving Day.
MORE►
by Lance Murray |
Jun 17, 2024
Researchers at Children's Hospital of Philadelphia and UT Southwestern analyzed T-cell receptors in nearly 500 blood samples from pre-diagnostic patients with ovarian cancer. The results point to the potential of testing for biomarkers 2 to 4 years before most cases of HGOC are currently diagnosed.
MORE►
Tech Titans innovation chair Andrew Olowu, CTO of Axxess, presents a $20K check for winning the Tech Titans Grand Challenge on edge computing to BALANCED | Media Technology’s CTO Dr. Corey Clark and CEO Robert M. Atkins. [Photo: Tech Titans]
McKinney-Based BALANCED Wins Tech Titans Award for Connecting Gamers and COVID Research Through Edge Computing
by David Seeley | Dec 10, 2021
BALANCED Media | Technology has won the second annual Grand Challenge competition for its edge computing solution. Gamers downloaded a small game. While they played, they were also processing data to help find COVID-fighting compounds.
Its HEWMEN crowd-computing platform
MORE►
by Alex Edwards |
Oct 15, 2020
The novel invention from researchers at Texas Woman’s University in Denton could greatly contribute to cancer treatment research. The compounds can prevent the growth of breast, lung, and colon cancer cells.
MORE►
by Nicholas Sakelaris |
Nov 28, 2016
The Dallas medical center received $5.8 million from the Cancer Prevention and Research Institute of Texas to fight cancer and attract new researchers.
MORE►
by Nealie Sanchez |
Sep 19, 2016
Its drug therapy for advanced or metastatic clear cell kidney cancer is in phase 1 clinical trials at UT Southwestern.
MORE►
Researcher’s Book Offers New Hope in Cancer Research
by Patrick Kobler | Feb 9, 2016
We connected with Dr. Theodora Ross, author of A Cancer in the Family, on why she came to DFW, UT Southwestern’s work in cancer genetics, and for her thoughts on how we can battle cancer more effectively.
MORE►
